Actinin, alpha 2 (ACTN2) Peptide
ACTN2
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN939512
Quick Overview for Actinin, alpha 2 (ACTN2) Peptide (ABIN939512)
Target
ACTN2
(Actinin, alpha 2 (ACTN2))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- IQSYSIRISS SNPYSTVTMD ELRNKWDKVK QLVPVRDQSL QEELARQHAN
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ACTN2 antibody,
Alternative Names: ACTN2 control peptide, ACTN2 antibody Blocking Peptide, Anti-ACTN2 Blocking Peptide, ACTN2, ACTN-2, ACTN 2, ACTN-2 Blocking Peptide, ACTN 2 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- ACTN2 (Actinin, alpha 2 (ACTN2))
-
Background
- The alpha-actinins are a multigene family of four actin-binding proteins related to dystrophin. The two skeletal muscle isoforms of alpha-actinin (ACTN2 and ACTN3) are major structural components of the Z-line involved in anchoring the actin-containing thin filaments. In humans, ACTN2 is expressed in all muscle fibres, while ACTN3 expression is restricted to a subset of type 2 fibres. Murine Actn2 and Actn3 are differentially expressed, spatially and temporally, during embryonic development and, in contrast to humans, alpha-actinin-2 expression does not completely overlap alpha-actinin-3 in postnatal skeletal muscle, suggesting independent function.
-
Molecular Weight
- 98 kDa
Target
-
You are here:
